Diagnostic testing solution for detection of SARS-CoV-2 virus in patient samples. Supports point-of-care and laboratory-based screening and confirmation of COVID-19 infection.
Manufactured by
Guangzhou Wondfo Biotech Co., Ltd.
Guangzhou, Guangdong, China
Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R D, manufacturing, sales and service of IVD industry , providing professional rapid diagnosis and chronic disease management solutions. Wondfo has 9 technology platforms . Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc . We provide services to over 150 countries and regions . In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China .
© 2026 Suplivia · Home · Browse Products